Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Quadruple-threat Rheumatologist

Gretchen Henkel  |  Issue: October 2010  |  October 1, 2010

Finding leisure time might be the only drawback in his busy life. Dr. Kvien and his wife enjoy spending time in their cabin in the mountains, hiking, fishing, and skiing. But as a past president of EULAR; current member of its Scientific Committee; and editor of the organization’s journal, Annals of the Rheumatic Diseases, Dr. Kvien keeps an active travel schedule. But this traveling is also interesting and fun, he says. “The strength of European rheumatology is the strong friendship between leading rheumatologists. It has been a pleasure also to follow the growing collaboration between ACR and EULAR.”

Tore Kvien has fostered long-time friendships in the rheumatology community. “Meetings in the area of rheumatology usually mean that you will have a good time, combined with good science and the opportunity to bring new information back to the clinical work and to the researchers.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Haugeberg says that he values the ways in which Dr. Kvien fosters a productive work atmosphere. “Often, in research, you can become so focused on results that you may forget to see the human being. The joy of working with him is that you feel that you are respected. I learned a lot from that perspective.”

Dr. Wolfe puts it this way: “There are two kinds of people who rise to the top of these organizations. Some compete as if it were a zero sum game. But that’s not what Tore Kvien does. He is happy when everybody succeeds.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Gretchen Henkel is writing the “Profiles in Rheumatology” series.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Professional TopicsProfilesResearch Rheum Tagged with:CareerDatabaseResearchRheumatoid arthritis

Related Articles

    Physician Maxime Dougados, MD, Is Intent on Advancing Clinical Measurement in Rheumatology

    September 1, 2013

    Visionary rheumatologist credited with developing new spondylarthritis criteria, collaborating on the OASIS study, and promoting the 3E Initiative in rheumatology

    Potential Benefits, Pitfalls of Biosimilars Reviewed at EULAR 2016

    September 8, 2016

    LONDON—The availability of a bio­similar form of infliximab has dramatically increased the number of Norwegians taking one form or another of the drug, an expert on biosimilars said in a debate-style session at the Annual Congress of the European League Against Rheumatism (EULAR 2016). The expanded uptake of Remicade (infliximab) and its biosimilar, Remsima (international…

    Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

    May 8, 2012

    Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

    The ACR/ARHP Awards Members for Contributions to Rheumatology

    December 15, 2015

    San Francisco is known for the Gold Rush, so it’s a particularly fitting place to collect a gold nugget. And so at the 2015 ACR/ARHP Annual Meeting in the Golden Gate City in November, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences